Korify Capital

Korify Capital is a Swiss-based venture capital firm focused on early and growth-stage investments in biotechnology with a particular emphasis on longevity/aging science and mental health. It was launched by the family office Infinitas Capital. The firm backs innovative technologies aiming to extend healthy lifespan and address major unmet needs in mental health. Its first fund targeted $100 million for investment across Europe, the US, and Israel. Portfolio highlights include Alto Neuroscience (AI-driven psychiatric drug development), Cambrian Biopharma (multi-program longevity therapeutics), Gameto (ovarian aging/fertility), Refoxy (FOXO modulators for age-related disease), Sensei Biotherapeutics (cancer immunotherapy) among others. The fund leverages deep sector expertise and networks to support transformative biotech ventures. No direct clinical results as it’s an investor; see individual portfolio company disclosures.